Strattera and Pregnancy
Strattera may not be safe to take during pregnancy. Strattera and pregnancy have not been tested together in humans, so the drug's possible effect on unborn children is unknown. However, Strattera did appear to cause harm to fetuses in previous animal studies. A healthcare provider may prescribe Strattera to a pregnant woman if he or she believes that its benefits outweigh the possible risks to her unborn child.
For women who are pregnant, Strattera® (atomoxetine hydrochloride) may not be safe. This is based on animal studies that looked at the effects of Strattera during pregnancy.
The U.S. Food and Drug Administration (FDA) uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but do appear to cause harm to the fetus in animal studies. Also, medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.
Strattera was given a pregnancy Category C rating because it was shown to cause problems in pregnant animals. When Strattera was given to pregnant rabbits, it caused increased miscarriages and problems of the blood vessels of the baby rabbits. When Strattera was given to rats during pregnancy and breastfeeding, the baby rats weighed less and were less likely to survive.
However, it is important to note that animals do not always respond to medicines in the same way that humans do. Therefore, a pregnancy Category C medicine may be given to a pregnant woman if her healthcare provider believes that its benefits outweigh any possible risks to her unborn child.